This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Walgreens January Sales Increase 3.7 Percent

Walgreens (NYSE: WAG) (Nasdaq: WAG) had January sales of $6.39 billion, an increase of 3.7 percent from $6.17 billion for the same month in fiscal 2013.

Total front-end sales increased 2.4 percent compared with the same month in fiscal 2013, while comparable store front-end sales increased 1.6 percent. Customer traffic in comparable stores decreased 2.2 percent while basket size increased 3.8 percent.

Prescriptions filled at comparable stores decreased by 0.8 percent in January and decreased 0.4 percent on a calendar day-shift adjusted basis. January 2014 had one additional Friday and one fewer Tuesday compared with January 2013. These calendar shifts negatively impacted prescriptions filled at comparable stores by 0.4 percentage point.

Prescriptions filled at comparable stores were negatively impacted by 0.8 percentage point due to fewer flu shots in the month versus last year and were negatively impacted by 1.4 percentage points due to the lower incidence of flu in January 2014.

January pharmacy sales increased by 4.6 percent, while comparable store pharmacy sales increased 3.7 percent and increased by a calendar day-shift adjusted 4.1 percent. Calendar day shifts negatively impacted pharmacy sales in comparable stores by 0.4 percentage point. Calendar day-shift adjusted comparable store pharmacy sales were negatively impacted by 1.3 percentage points due to generic drug introductions in the last 12 months, and were negatively impacted by 0.5 percentage point due to fewer flu shots in January versus last year. The lower incidence of flu negatively impacted pharmacy sales by 1.1 percentage points. Pharmacy sales accounted for 65.6 percent of total sales for the month.

Flu shots administered at pharmacies and clinics season to date were more than 7.5 million versus nearly 6.9 million last year.

Sales in comparable stores increased by 2.9 percent in January. Calendar day shifts negatively impacted total comparable sales by 0.3 percentage point, while generic drug introductions in the last 12 months negatively impacted total comparable sales by 0.9 percentage point.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs